Atypical pilocytic astrocytoma of the third ventricle appearing as a colloid cyst.

Klin Neuroradiol

Evangelisches und Johanniter Klinikum Niederrhein, Duisburg, Germany.

Published: December 2009

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00062-009-9016-xDOI Listing

Publication Analysis

Top Keywords

atypical pilocytic
4
pilocytic astrocytoma
4
astrocytoma third
4
third ventricle
4
ventricle appearing
4
appearing colloid
4
colloid cyst
4
atypical
1
astrocytoma
1
third
1

Similar Publications

BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center's experience.

Front Oncol

January 2025

Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, GA, United States.

Background: Pediatric low-grade gliomas (pLGGs) have an overall survival of over 90%; however, patients harboring a BRAF alteration may have worse outcomes, particularly when treated with classic chemotherapy. Combined BRAF/MEK inhibition following incomplete resection demonstrated improved outcome in BRAF altered pLGG compared to combined carboplatin/vincristine chemotherapy and is now considered the standard FDA-approved treatment for this group of tumors. The aim herein was to investigate the efficacy and tolerability of single agent BRAF inhibitor treatment in BRAF altered pLGG.

View Article and Find Full Text PDF

Analysis of Spinal Pilocytic Astrocytoma in 12 Case Reports and Literature Review.

J Belg Soc Radiol

September 2024

Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China.

Spinal pilocytic astrocytoma (PA) is a rare disorder with atypical, clinical and imaging characteristics, and generally limited to case reports. We analysed the clinical manifestations, imaging findings, treatment and prognostic follow-up of 12 patients with spinal PA admitted from January 2010 to July 2021, and reviewed the relevant literature. Radiological assessment, especially magnetic resonance imaging, can help to provide effective diagnostic information.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores the use of cell-free DNA (cfDNA) from blood and cerebrospinal fluid (CSF) for diagnosing and selecting treatment for children with primary central nervous system (CNS) tumors, providing a safer alternative to traditional neurosurgical biopsies.
  • CSF samples were collected from pediatric patients with various types of CNS tumors and analyzed using a next-generation sequencing platform, revealing that cfDNA can yield significant genetic information about the tumors.
  • The findings show that genomic alterations in pediatric brain tumors can be detected in CSF-derived cfDNA, with a high concordance rate to tissue samples, highlighting the potential of liquid biopsy in clinical settings.
View Article and Find Full Text PDF

This case report describes the presentation, diagnostic evaluation, and management challenges encountered in an eight-month-old female infant with fever, seizure, and a large cystic brain lesion initially diagnosed as pilocytic astrocytoma but later demonstrating atypical teratoid/rhabdoid tumor (AT/RT) features on histopathological examination-the infant presented with a fever and cold persisting for 10 days, followed by a seizure episode. Laboratory investigations revealed abnormalities, including anemia and leukocytosis. Imaging studies identified a large cystic lesion causing hydrocephalus.

View Article and Find Full Text PDF

Pilocytic astrocytoma (PA), recognized as the most prevalent central nervous system (CNS) tumor, has long been associated with calcifications, a characteristic often attributed to benign or indolent growth patterns. In this study, we explored the calcified attributes in these tumors that beckon a deeper understanding. This is a retrospective study, on a set of seven cases, with a histopathological diagnosis of pilocytic astrocytoma with calcifications and psammoma bodies (PB).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!